Caris Life Sciences, Inc.
HealthcareNASDAQ:CAI · NASDAQ Global Select
-$0.03 today
Vol 1.96M · Avg 2.67M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
-35.82%
Period High
$39.30
Period Low
$14.55
Latest
$17.97
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Moderna, Inc.
NASDAQ:MRNA
$19.80B
Jazz Pharmaceuticals plc
NASDAQ:JAZZ
$14.48B
Madrigal Pharmaceuticals, Inc.
NASDAQ:MDGL
$11.08B
Corcept Therapeutics Incorporated
NASDAQ:CORT
$8.90B
Cytokinetics, Incorporated
NASDAQ:CYTK
$8.73B
Halozyme Therapeutics, Inc.
NASDAQ:HALO
$8.24B
Merus N.V.
MRUS
$6.83B
Abivax S.A.
NASDAQ:ABVX
$6.33B
Rhythm Pharmaceuticals, Inc.
NASDAQ:RYTM
$6.06B
Atrium Therapeutics, Inc.
NASDAQ:RNA
$211.60M
What is the latest CAI filing?
The latest filing shown is 8-K dated Jun 5, 2026.
How many recent filings does CAI have?
Intrinsic Alpha currently shows 20 recent filings for CAI.
Explore More
Continue the stock analysis
Jump to another research area for this company.